$CTIX News Cellceutix jumps on QIDP tag 1:23 p.m. Dec.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CTIX News

Cellceutix jumps on QIDP tag 1:23 p.m. Dec. 8, 2014 - Seeking Alpha
Cellceutix Brilacidin IND effective, Phase 2 to begin 9:31 a.m. Oct. 13, 2014 - Seeking Alpha
Regulatory Support Creates Opportunity For Antibiotic Makers Otonomy And Cellceutix 9:02 a.m. Sept. 25, 2014 - Seeking Alpha
Update: Cellceutix Calls Out To President Obama About Brilacidin 2:38 p.m. Sept. 21, 2014 - Seeking Alpha
10-K: CELLCEUTIX CORP 12:53 p.m. Sept. 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol 2:06 a.m. Sept. 14, 2014 - Seeking Alpha
The Antibiotic Resistance Triple Threat 1:05 p.m. Sept. 4, 2014 - Seeking Alpha
Cellceutix completes enrollment in Brilacidin trial 8:45 a.m. Aug. 19, 2014 - Seeking Alpha
Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market? 10:38 a.m. Aug. 14, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 9:15 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix 9:34 a.m. April 25, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 4:09 p.m. Feb. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin 9:31 a.m. Jan. 28, 2014 - Seeking Alpha
Cellceutix Corp.: A Biotech With High Risk But High Reward 3:17 p.m. Jan. 2, 2014 - Wall St. Cheat Sheet
Cellceutix: An Undiscovered Company Set To Rise In 2014 9:06 a.m. Dec. 16, 2013 - Seeking Alpha
3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference 5:38 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: CELLCEUTIX CORP 5:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: CELLCEUTIX CORP 3:01 p.m. Sept. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: CELLCEUTIX CORP 1:18 p.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
Interview with CEO of Cellceutix Corporation: Leo Ehrlich 8:57 a.m. Nov. 15, 2011 - GuruFocus.com


Cellceutix: Prurisol(TM) for Psoriasis -- FDA Agrees That Phase 2 Study May Begin 7:41 a.m. Dec. 10, 2014 - Marketwired
Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA 7:01 a.m. Dec. 8, 2014 - Marketwired
Cellceutix: December to Be Momentous Month in Company's History 7:02 a.m. Nov. 24, 2014 - Marketwired
These Medical Stocks Are Reaching A Fever Pitch Following Midterm Elections 9:54 a.m. Nov. 12, 2014 - ACCESSWIRE
Patient Enrollment in Cellceutix Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis Targeted to Begin in December 2014 7:01 a.m. Nov. 11, 2014 - Marketwired
Cellceutix's New Chief Operating Officer Dr. James Alexander Addresses Shareholders 6:00 a.m. Oct. 31, 2014 - Marketwired
Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; Single-Dose Brilacidin Comparable to 7-Days of Daptomycin 10:52 a.m. Oct. 23, 2014 - Marketwired
Cellceutix Investigational New Drug (IND) Application Becomes Effective, Selects First Site for Phase 2 Clinical Trial of New Treatment for Oral Mucositis 8:02 a.m. Oct. 13, 2014 - Marketwired
Cellceutix Provides Update to Shareholders 11:30 a.m. Sept. 24, 2014 - Marketwire
Cellceutix to President Obama: We Have the Tools and Will Rise Up to the Challenge to Prevent Antibiotic Resistant Bacteria Becoming a Serious Threat to Public Health 6:15 a.m. Sept. 19, 2014 - Marketwire
Cellceutix Provides Initial Observations of Completed ABSSSI Phase 2b Trial; Company Submits Investigational New Drug Application to FDA for Phase 2 Trial of Brilacidin-OM for Oral Mucositis 2:01 p.m. Sept. 9, 2014 - Marketwire
Cellceutix to Present at Rodman & Renshaw's 16th Annual Global Investment Conference 10:17 a.m. Sept. 5, 2014 - Marketwire
Cellceutix Appoints Dr. Barry Schechter to Board of Directors as Company Focuses on Meeting Requirements for Stock Exchange Uplisting 6:01 a.m. Sept. 2, 2014 - Marketwire
Cellceutix Completes Enrollment in Phase 2b Clinical Trial of Brilacidin for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 7:31 a.m. Aug. 19, 2014 - Marketwire
Cellceutix Prepares for Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis 6:01 a.m. Aug. 11, 2014 - Marketwire
Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical Trial 5:04 a.m. Aug. 8, 2014 - Marketwire
Cellceutix Believes Brilacidin on Track to Help U.S. Avoid Falling Into Post-Antibiotic Era; Completion of Enrollment in Phase 2b Trial for Acute Bacterial Skin and Skin Structure Infections Expected This Month 6:01 a.m. Aug. 4, 2014 - Marketwire
Cellceutix Announces Breakthrough in the Formulation of Its Novel Antibiotic Brilacidin(TM), Plans Studies to Treat Diabetic Foot Ulcers 6:01 a.m. July 14, 2014 - Marketwire
Cellceutix Brilacidin ABSSSI Trial Gets Positive Review by Data Safety Monitoring Board; Best Possible Outcome, No Treatment-Related Serious Adverse Events (SAEs) 6:00 a.m. July 7, 2014 - Marketwire
Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant 6:01 a.m. June 23, 2014 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UFP Industries Fortifies Gulf Coast with $27M Buy

Updated Category News Views 65

UFP Industries Makes a Strategic Move Folks, it looks like UFP Industries (NASDAQ: UFPI) is making some solid moves down in the Gulf Coast, and they're shelling out $27 million to do it. This time, they've got their eyes on Apache Products, dba Acme Skid, a company that's been doing the heavy lifting in the pallet manufacturing space in Silsbee, Texas. Apparently, these...

Continue Reading
New Leadership at Bottle Rocket: Tom Bateman Steps In

Updated Category News Views 46

An Unexpected Move in Digital Product Leadership You know, just when you think the digital realm can't throw another card down, Bottle Rocket pulls out something from its hat by snapping up Tom Bateman. This fella's got three solid decades of experience under his belt, working his magic on digital product and experience gigs for the Fortune 500 gang. Now, that's no walk...

Continue Reading
AVANT BIO Beef Up Team with Heavyweights Lio, Vanek

Updated Category News Views 138

AVANT BIO's Latest Power Play Alright, here's a big splash in the gene pool of life sciences—AVANT BIO just drafted two industry veterans, Peggy Lio and Philip Vanek, into their Operating Advisor Hall of Fame. And these folks aren't just window dressing. They're packing experience from some of the big hitters like GE Healthcare and Lonza, ready to roll up their sleeves...

Continue Reading
Cognizant & EBRD Unite for Tech Transformation Push

Updated Category News Views 129

An Unexpected Collaboration to Watch Sometimes partnerships come out of left field, like this one between Cognizant and the European Bank for Reconstruction and Development (EBRD). These two are teaming up to inject some serious tech smarts into the Bank's operations over the next five years. What's interesting here is the role AI and automation play in their grand...

Continue Reading
Global Movement Countdown Begins with The Power Hour™

Updated Category News Views 0

Imagine a world where everyone stands up and moves for sixty minutes. That's the idea behind The Power Hour™, a bold initiative launched straight from TikTok Headquarters in New York City. On October 26, 2026, this ambitious global movement embarked on a 365-day countdown to a world-record attempt in October 2027. The mission? To transform movement into widespread...

Continue Reading
Innventure Faces Legal Scrutiny Over DarkNX Debacle

Updated Category News Views 81

Innventure’s Market Tumult: Unraveling the Drama Talk about a mess. Innventure Inc. (NASDAQ: INV) investors are likely feeling a sting sharper than a bee that's lost its hive after a painful 55% stock crash back in August 2026. The culprit? A scuttled project involving a shadowy partner, DarkNX, and a lot of questions about who knew what and when. A Puzzling...

Continue Reading
Touchmark's Q3 Bonanza: Income Leaps 39%, Stock Repurchase

Updated Category News Views 59

Ever seen a bank juggle financials like a street performer with flaming torches? That's Touchmark Bancshares for you this quarter. This Georgia-based community bank just released their third quarter 2026 results, and it seems they've not only mastered performance but also pranced around market risks effortlessly, much to the delight of investors. Breaking Down the Numbers...

Continue Reading
TrueLoyal Finds New Loyalty Chief: Thompson Steps Up

Updated Category News Views 0

Shaking Up Loyalty: TrueLoyal's Bold Move You know, in an era when brands are trying everything to keep customers from jumping ship, getting someone like Erica Thompson on board is like snagging a golden ticket. TrueLoyal just announced they’ve tapped into a veteran, a real heavy-hitter in the loyalty game, to head their loyalty strategy, customer retention, and...

Continue Reading
Pii's Odyssey Ignites Epic Cosmic Adventure

Updated Category News Views 0

A Cosmic Journey Begins Well, here's a fresh start to a galactic escapade or two! LaMont Schiers, with his brain teeming post a vivid dream, plunges headfirst into the science fiction scene. 'Pii's Odyssey: The Eternals' isn't your average bedtime read. Oh no, this is where a 14-year-old warrior kid named Pii gets yanked from his comfy home planet and tossed into a...

Continue Reading
Epic Oceanside Estate Set for No-Reserve Luxury Auction

Updated Category News Views 0

Going, Going, Gone? A Golf Exec's Dream Home What's hotter than Florida's summer sun? It's this swanky estate at Ponte Vedra Beach set to hit the auction block without any safety net. Yup, no reserve, folks! Leonard "Len" Brown, Jr., the brains behind many of PGA Tour's global ventures, has decided to put his lavish 3.2-acre plot right by the ocean up for grabs. Once...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Insights into Recent Mergers: A Look at YOTA, PORT, ACCD, ESSA

Updated Category News Views 257

Understanding Recent Mergers and Their Implications As the merger activity heats up in the corporate world, we find ourselves at a fascinating juncture where various companies are joining forces. This article explores notable mergers including Yotta Acquisition Corporation, Southport Acquisition Corporation, Accolade, Inc., and ESSA Bancorp, offering insights from legal...

Continue Reading
LHV Group Reports Strategic Share Buybacks on Tallinn Exchange

Updated Category News Views 108

LHV Group's Recent Share Acquisition Activities LHV Group has recently taken significant steps towards enhancing its shareholder value by acquiring its own shares on the Nasdaq Tallinn Stock Exchange. This acquisition occurred during a specified period, demonstrating the company's proactive approach in a fluctuating market. Detailing Share Acquisition Summary The company...

Continue Reading
Supporting Afghan Girls: A Call for Education Equality

Updated Category News Views 291

Standing with Afghan Girls: An Urgent Call to Action As we observe another year since the ban on secondary education for girls, it’s crucial to keep in mind the struggles faced by Afghan girls and women. This situation underscores an urgent need to mobilize efforts aimed at securing their fundamental right to education, a right that has been stripped away under harsh...

Continue Reading
Consumers Energy Foundation Fuels Workforce Development with $150K

Updated Category News Views 194

Consumers Energy Foundation Invests in Community Development The Consumers Energy Foundation has made a significant commitment to community development by awarding $150,000 to the Michigan AFL-CIO Workforce Development Institute (WDI). This funding is aimed at fostering a new workforce cohort for their innovative Access for All program. The initiative is designed to...

Continue Reading
Carter's Earnings Report Anticipation and Market Insights

Updated Category News Views 225

Carter's Earnings Report Overview Carter's (NYSE: CRI) is set to announce its quarterly earnings soon. This forthcoming report has many investors eagerly anticipating the financial outcomes and insights that will follow. As we approach this significant date, understanding what to expect can provide valuable context for stakeholders. Analysts' Expectations Experts are...

Continue Reading